Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-20

Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study investigates whether fostamatinib alters blood concentrations of an oral contraceptive in healthy female subjects to assess potential drug-dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostamatinib (fostamatinib)
  • Oral contraceptive

Snippet

Sponsor: AstraZeneca | Conditions: Scientific Terminology Rheumatoid Arthritis, Healthy Female Volunteers, Pharmacokinetics, Oral Contraceptive, Drug-drug Interaction, Laymen Terminology Level of Oral Contraceptive in Blood, Oral Contraceptive, Rheumatoid Arthritis, Drug -Drug Interaction | Phase 1 | Status: COMPLETED